STAR-0310

Astria Therapeutics, Inc. · Phase 1 active Small molecule

At a glance

Generic name	STAR-0310
Sponsor	Astria Therapeutics, Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study of STAR-0310 in Healthy Adult Participants (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

STAR-0310 CI brief — competitive landscape report
STAR-0310 updates RSS · CI watch RSS
Astria Therapeutics, Inc. portfolio CI